Avalon Pharmaceuticals to Present at Bank of America Annual Health Care Conference 2006
May 15 2006 - 2:15PM
PR Newswire (US)
GERMANTOWN, Md., May 15 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX), a
biopharmaceutical company focused on the discovery and development
of small molecule therapeutics, today announced that Kenneth Carter
Ph.D., President and CEO, is scheduled to provide an update on the
Company at the Bank of America Health Care Conference 2006. The
conference will be held at the Four Seasons Hotel in Las Vegas, NV
on May 16-18, 2006. Dr. Carter is scheduled to present on Thursday,
May 18th at 12:40 p.m. PDT - 3:40 p.m. EDT. The presentation will
be available live via a webcast and can be accessed through the
investor page of Avalon Pharmaceuticals' website at:
http://www.avalonrx.com/. An archive of the presentation will be
available through June 2, 2006. About Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals is a biopharmaceutical company focused on
the discovery and development of small molecule therapeutics.
Avalon seeks to discover and develop novel therapeutics through the
use of a comprehensive, innovative and proprietary suite of
technologies based upon large-scale gene expression analysis which
it calls AvalonRx(R). Avalon Pharmaceuticals was established in
1999 and is headquartered in Germantown, Maryland. Contacts: Avalon
Pharmaceuticals, Inc. Noonan Russo Gary Lessing Wendy Lau (Media)
Executive Vice President & CFO Tel: (212) 845-4272 Tel: (301)
556-9900 Fax: (301) 556-9910 Jane Petrino (Investors) Email: Tel:
(212) 845-4274 DATASOURCE: Avalon Pharmaceuticals, Inc. CONTACT:
Gary Lessing, Executive Vice President & CFO of Avalon
Pharmaceuticals, Inc., +1-301-556-9900, Fax: +1-301-556-9910, ; or
Media: Wendy Lau, +1-212-845-4272, or Investors: Jane Petrino,
+1-212-845-4274, both of Noonan Russo, both for Avalon
Pharmaceuticals, Inc. Web site: http://www.avalonrx.com/
Copyright